Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Bharat Parenterals

Sector: Healthcare | Industry: Drugs & Pharma
R 171.95 -9.05  | -5.00% -13.51% 4.32 98.52
BSE Price: Dec 10, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 10, 2019 171.95 -9.05 -5.00% 171.95 181.00 147 171.95 - 171.95
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue-219.54136.58111.44124.11 --
Other Income-12.747.177.715.05 --
Total Income-232.28143.74119.15129.16 --
Total Expenditure-190.69124.44104.98114.12 --
Operating Profit-41.5919.3014.1815.04 --
Interest-0.870.940.911.49 --
PBDT-40.7218.3613.2713.55 --
Depreciation-6.135.575.794.20 --
PBT & Exceptional Items-34.5912.797.489.35 --
Exceptional Items----- --
Profit before Tax-34.5912.797.489.35 --
Provision for Tax-13.353.680.592.89 --
Profit after Tax-21.259.126.896.45 --
Minority Interest----- --
Share of Associate----- --
Consolidated Profit-21.259.126.896.45 --
 
LiabilitiesR Cr
Share Capital5.735.735.735.735.73 --
Total Reserves97.1688.2867.1257.9550.96 --
Shareholder's Funds102.8994.0172.8563.6856.69 --
Minority Interest-0.000.000.00- --
Long Term Borrowings0.770.972.344.016.90 --
Other Non Current Liabilities3.733.450.080.000.50 --
Current Liabilities69.9560.5156.8842.7956.18 --
Total Debt*-4.848.766.4119.43 --
Total Liabilities177.34158.93132.15110.48120.26 --
 
AssetsR Cr
Net Block32.5433.9833.7131.1634.69 --
Non Current Investments1.331.36-0.550.50 --
Other Non-Current Assets11.165.577.6114.7813.46 --
Current Investments14.351.470.52-- --
Cash and Bank4.3712.134.131.5812.74 --
Other Current Assets113.60104.4286.1862.4058.87 --
Net Current Assets62.3757.5133.9421.2015.44 --
Miscellaneous Exp. Not Written Off----- --
Total Assets177.35158.93132.15110.48120.26 --
 
Cash FlowR Cr
From Operations-20.436.34-2.11- --
From Investing Activities--9.36-8.07-1.53- --
From Finance Activities--3.894.04-7.52- --
Net Inflow/Outflow-7.182.30-11.160.00 --
 
Key Ratios
Adjusted EPS (Rs)37.0837.0815.9112.0311.26 --
Adjusted Book Value (Rs)179.57164.07127.14111.1498.95 --
Dividend per Share (Rs)-0.000.000.000.00 --
Cash Flow per Share (Rs)-35.6611.06-3.680.00 --
Debt to Equity0.010.050.120.100.34 --
Current Ratio1.891.951.601.501.27 --
ROCE (%)-39.3018.1011.4714.23 --
RONW (%)-25.4713.3511.4511.38 --
Operating Margin (%)-18.9414.1312.7212.11 --
Net Margin (%)-9.156.345.795.00 --
Revenue Growth (%)-60.7522.55-10.200.00 --
Net Profit Growth (%)-133.0832.236.830.00 --
EPS Growth (%)-133.0832.236.830.00 --
Book Value Growth (%)-29.0514.4012.320.00 --
 
Market Cues
Close Price (Rs)171.95220.00203.50-- --
High Price (Rs)258.80325.35203.50-- --
Low Price (Rs)152.00116.25152.00-- --
Market Cap (Rs Cr)98.52126.05116.600.000.00 --
Price / Earnings4.645.9312.790.000.00 --
Price / Book Value0.961.341.600.000.00 --
Dividend Yield (%)0.000.000.00-- --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
4.26
Piotroski F-Score
8
Modified C-Score
0
1-Year Price to Earnings
4.32
1-Year Price to Book
0.92
Earnings Yield
EBIT / Enterprise value
36.86%
PEG
Price / Earnings to growth ratio
0.02
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,697.95 +1.00%
Eris Lifesciences R473.40 -0.50%
FDC R206.60 -0.17%
Granules India R124.20 -0.56%
JB Chemicals & Pharma R418.60 -0.89%
Laurus Labs R333.10 -0.45%
Procter & Gamble Health R4,145.00 -0.87%
Strides Pharma Science R367.00 -1.14%
Sun Pharma Adv. Research R163.40 -3.91%
Suven Life Sciences R267.80 +0.96%
As on Dec 11, 11:24